Search results
Results from the WOW.Com Content Network
One point is assigned for each of the following risk factors: [citation needed] Age greater than 60 years; Stage III or IV disease; Elevated serum LDH; ECOG/Zubrod performance status of 2, 3, or 4; More than 1 extranodal site; The sum of the points allotted correlates with the following risk groups: Low risk (0-1 points) - 5-year survival of 73%
A Risk Class I or Risk Class II pneumonia patient can be sent home on oral antibiotics. [4] A Risk Class III patient, after evaluation of other factors including home environment and follow-up, may either: [5] be sent home with oral antibiotics [4] be admitted for a short hospital stay with antibiotics and monitoring. [4]
Prognosis (Greek: πρόγνωσις "fore-knowing, foreseeing"; pl.: prognoses) is a medical term for predicting the likelihood or expected development of a disease, including whether the signs and symptoms will improve or worsen (and how quickly) or remain stable over time; expectations of quality of life, such as the ability to carry out daily activities; the potential for complications and ...
Prognostic markers are biomarkers used to measure the progress of a disease in the patient sample. [1] Prognostic markers are useful to stratify the patients into groups, guiding towards precise medicine discovery. The widely used prognostic markers in cancers include stage, size, grade, node and metastasis. In addition to these common markers ...
I – Investigated condition (e.g. intervention, exposure, risk/ prognostic factor, or test result) C – Comparison condition (e.g. intervention, exposure, risk/ prognostic factor, or test result respectively) O – Outcome(s) (e.g. symptom, syndrome, or disease of interest) Alternatives such as SPICE and PECO (among many others) can also be used.
Prognostic factors are often used in combination with predictive variables in therapeutics studies, to examine how effective different treatments are in curing specific diseases or cancer. As opposed to predictive biomarkers, prognostic do not rely on any explanatory variables, thus allowing for independent examination of the underlying disease ...
The International Prognostic Scoring System (IPSS), originally published in 1997, is used by many doctors to help assess the severity of a patient's myelodysplastic syndrome (MDS). Based on the IPSS score, the patient's history, and the physician's own personal observations, the physician will design a treatment plan to address the MDS.
In epidemiology, a risk factor or determinant is a variable associated with an increased risk of disease or infection. [ 1 ] : 38 Due to a lack of harmonization across disciplines, determinant , in its more widely accepted scientific meaning , is often used as a synonym.